Unfortunately, when looking at potential of erhc, one has to separate the company and insiders from all the other erhe shareholders.
A few simple facts:
erhc is operating like a private company and has been silent for over 4 years.
erhc has done nothing to increase shareholder value for over 4 years and is facing possible revocation of its shares by the SEC because of its refusal to comply with SEC regulations.
No erhc insider has purchased shares since before the 1:100 reverse split years ago.
Only 1 person owns more than 5% of erhe shares and he/she has acknowledged having no clue about what might or might not be going on inside the company. This 5%+ position was acquired in a failed attempt to prove averaging down (relabeled as dilution insurance) of a toxic debt laden company with maxed out authorized shares is a viable investing strategy. How's that working out? Big clue: price near zero, volume near zero for years.
Clearly insiders are in a position to benefit from any future erhc success and leave all the other current erhe shareholders exactly where they are and have been for over 4 years - in the dark and stuck with worthless shares.